Stay updated on Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Sign up to get notified when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changes from v3.7.1 to v3.7.2. The study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-18T16:12:01.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T16:40:38.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 entry is added to the record history. The previous Revision: v3.6.6 is removed, updating the page’s version-history display to reflect the latest platform release.
    Difference
    0.1%
    Check dated 2026-09-20T19:56:15.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The page's record history shows Revision: v3.6.6 instead of v3.6.5, indicating a software/UI revision in the history metadata. This change is metadata and does not alter trial data or the content of the study record.
    Difference
    0.1%
    Check dated 2026-08-30T15:17:55.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    New revision entry v3.6.5 was added to the record history, replacing v3.6.4. This reflects a minor update to the page's revision metadata rather than substantive study information.
    Difference
    0.1%
    Check dated 2026-08-09T08:41:20.000Z thumbnail image
  7. Check
    86 days ago
    Change Detected
    Summary
    The record history now shows the latest revision, updating from v3.6.3 to v3.6.4.
    Difference
    0.1%
    Check dated 2026-07-25T16:55:30.000Z thumbnail image

Stay in the know with updates to Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Canakinumab & Pembrolizumab Combo in Early NSCLC Clinical Trial page.